Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Breakthrough cancer drug offers hope for Alzheimer patients
October 27th, 2003
The laboratories of the Fisher Center for Research on Alzheimer's Disease at the Rockefeller University in New York City report that a novel cancer drug hailed in recent years for its ability to halt a deadly form of leukemia and stomach cancer may offer new hope for those afflicted with the mind-robbing ravages of Alzheimer disease. The new study carried out by researchers at the Fisher Center was published in the Proceeding of the National Academy of Sciences USA. The drug, called Gleevec, was shown to lower production of a toxic substance called beta-amyloid that is thought to underlie the development of Alzheimer disease. This was shown in...
Source: Health & Medicine Week (2003-10-27)
|
